Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding

References

• Adlercreutz H., Eisalo A., Heino A., Luukkainen T., Penttilä I., Saukkonen H. Investigations on the effect of an oral contraceptive and its components on liver function, serum proteins, copper, cerulo-plasmin and γ-glutamyl peptidase in postmeno-pausal women. Scand. J. Gastroent 1968; 3: 213
   Google Scholar
• Anderson D. C. Sex-hormone-binding globulin. Clin. Endocr 1914; 3: 68
   Google Scholar
• Barbosa J., Seal U. S., Doe R. P. Effects of anabolic steroids on hormone-binding proteins, serum cortisol and serum non-protein-bound cortisol. J. clin. Endocr 1971; 32: 232
   PubMedGoogle Scholar
• Barbosa J., Seal U., Doe D. P. Effects of anabolic steroids on haptoglobin, orosomucoid, plasminogen transferrin, ceruloplasmin, α-antitrypsin, β-glucu-ronidase and total serum proteins. J. clin. Endocr 1971; 33: 388
   PubMed Web of Science ®Google Scholar
• Bergink E. W., Wolf D. L., Wittliff J. L., Bruining G. L., Bryson M. F., Forbes G. B. Testosterone-estradiol-binding globulin in patients with Turner's syndrome: Effects of estrogens and acute growth hormone administration. J. clin. Enducr. Metab 1976; 42: 1018
   PubMedGoogle Scholar
• Bergink E. W., Hamburger A. D., de Jager E., van der Vies J. Binding of a contraceptive pro-gestogen Org 2969 and its metabolites to receptor proteins and human sex-hormone binding globulin. J. Steroid Biochem 1981; 14: 175
   PubMedGoogle Scholar
• Bernutz C., Hänsle W. O., Horn K., Pickardt C. R., Scriba P. C., Fink E., Kolb H., Tschenke H. Isolation, characterization and radioimmuno-assay of corticosteroid-binding globulin in human serum—clinical significance and comparison to thyroxine-binding globulin. Acta endocr 1979; 92: 370
   PubMedGoogle Scholar
• Briggs M. H., Briggs M. Effects of oral ethinyl-oestradiol on serum proteins in women. Contraception 1971; 3: 381
   Web of Science ®Google Scholar
• Briggs M. H. Hormonal contraceptives and plasma sex-hormone binding globulin. Contraception 1975; 12: 149
   PubMedGoogle Scholar
• Briggs M. H. Effects of oral Drogestogens on estrogen induced changes in plasma proteins. J. reprod. Med 1975; 15: 100
   PubMed Web of Science ®Google Scholar
• Briggs M. H. Biochemical basis for the selection of oral contraceptives. Int. J. Gynaec. Obstet 1979; 16: 509
   Google Scholar
• Burke C. W., Anderson D. C. Sex-hormone-binding globulin is an oestrogen amplifier. Nature 1972; 240: 38
   PubMed Web of Science ®Google Scholar
• Cullberg G., Dovré P.A., Lindstedt G., Steffensen K. On the use of plasma proteins as indicators of the metabolic effects by combined oral contraceptives. Acra Endocrinol., Suppl., In press
   Google Scholar
• Dickinson P., Zinneman H.H., Swaim W.R., Doe R.P., Seal U.S. Effects of testosterone treatment on plasma proteins and amino-acids in men. J. clin. Endocr 1969; 29: 837
   Google Scholar
• El Makhzangy M. N., Wynn V., Lawrence D. M. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin. Endocr 1979; 10: 39
   PubMedGoogle Scholar
• Van Kammen E., Thyssen J. H.H., Rademaker B., Schwarz F. The influence of hormonal contraceptives on sex hormone binding globulin capacity. Contraception 1975; 11: 53
   PubMed Web of Science ®Google Scholar
• Kley H. K., Herrman J., Morgner K. D., Krueskemper H. L. Effects of testosterone oenan-thate on plasma concentrations of thyroxine, cortisol, testosterone and hormone binding proteins in patients with hypogonadism. Horm. Metab. Res 1973; 5: 271
   PubMedGoogle Scholar
• Kley H. K., Krueskemper H. L. Leber und Steroidhormone. 11. Beeinflussung des Leberstoff-wechsels durch Steroidhormone. Med. Klin 1977; 72: 231
   PubMedGoogle Scholar
• Laurell C. B., Rannevik G. A comparison of plasma protein changes induced by danazol, pregnancy and oestrogens. J. clin. Enducr. Metab 1979; 49: 719
   PubMed Web of Science ®Google Scholar
• Lutz R. A., Märka H. H., Weder H. G. Die Androgenbindung im menschlichen Plasma und ihre physiologische Bedeutung. J. clin. Chem. clin. Biochem 1977; 15: 57
   PubMedGoogle Scholar
• Mickelson K. E., Petra P. H. A filter assay for the sex steroid binding protein of human serum. TEBS Let 1974; 44: 34
   Google Scholar
• Mol G. W., Rosenfield R. L. Testosterone binding and free plasma androgen concentrations under physiological conditions: Characterization by flow dialysis technique. J. clin. Endoer. Metab 1979; 49: 730
   PubMedGoogle Scholar
• Nash E. J., Cormish E. J., Hain R. Metabolic effects of oral contraceptives containing 30 micro-grams and 50 micrograms of oestrogens. Med. J. Aust 1979; 2: 277
   PubMedGoogle Scholar
• Rosenfield R. L. Studies of the relation of plasma androgen levels to androgen action in women. J. Steroid Biochem 1975; 6: 695
   PubMedGoogle Scholar
• Schiller H. S., Petra P. H. A filter assay for the corticosteroid binding globulin of human serum. J. Steroid Biochem 1976; 7: 55
   PubMedGoogle Scholar
• Schosinsky K. H., Lehman H. P., Beller M. F. Measurement of ceruloplasmin from its oxidase activity in serum by use of O-dianisidine dihydro-chloride. Clin. Chem 1974; 20: 1556
   PubMed Web of Science ®Google Scholar
• Schwartz U., Hammerstein J. The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity. Acta endocr 1974; 16: 159
   Google Scholar
• Tremblay R. R., Dubé J.Y. Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 1974; 10: 599
   PubMed Web of Science ®Google Scholar
• Vermeulen A., Stoica T., Verdonck L. The apparent free testosterone concentration, an index of androgenicity. J. clin. Endocr 1971; 33: 759
   PubMed Web of Science ®Google Scholar
• Vermeulen A., Verdonck L. Studies on the binding of testosterone to human plasma. Steroids 1968; 11: 609
   PubMed Web of Science ®Google Scholar
• Viinikka L., Hirvonen E., Ylikorkala O., Nummi S., Virkkunen P., Ranta T., Alapiessa U., Vihko R. Ovulation inhibition by a new low dose progestagen. Contraception 1977; 16: 51
   PubMedGoogle Scholar
• Wagner R. K. Extra-cellular and intra-cellular steroid binding moteins. Prooerties. discrimination. assay and clin&il applications. Acta Endocr. Kbh 1978; 88: 1, Suppl. 218
   PubMedGoogle Scholar